Cundy Kenneth C has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 115037 shares of Anebulo Pharmaceuticals, Inc. ($ANEB) on April 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 115037 | $0.00 | 115,037.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 72613 | $0.00 | 72,613.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Cundy Kenneth C | Chief Scientific Officer | A | Stock Option (right to buy) | 72613 | $0.00 | 72,613.0000 | 0 | 9999.99% | 0.00% |